Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Stock

Equities

600866

CNE000000H46

Food Processing

End-of-day quote Shanghai S.E. 06:00:00 2024-05-16 pm EDT 5-day change 1st Jan Change
7.17 CNY -6.88% Intraday chart for Star Lake Bioscience Co., Inc.Zhaoqing Guangdong -10.49% +53.86%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 17.75B 2.46B Sales 2025 * 18.76B 2.6B Capitalization 11.91B 1.65B
Net income 2024 * 1.1B 152M Net income 2025 * 1.22B 169M EV / Sales 2024 * 0.67 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.63 x
P/E ratio 2024 *
10.9 x
P/E ratio 2025 *
9.82 x
Employees 9,012
Yield 2024 *
3.91%
Yield 2025 *
4.18%
Free-Float 36.69%
More Fundamentals * Assessed data
Dynamic Chart
China stocks down, dragged by cyclical shares; HK shares up RE
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Full Year Ended December 31, 2023 CI
CJ Cheiljedang Files 20 Million Yuan Patent Case Against Star Lake Bioscience's Unit MT
Guangxin Bio-Intelligent Manufacturing Technology Innovation Co., Ltd. announced that it has received CNY 120 million in funding from Star Lake Bioscience Co., Inc.Zhaoqing Guangdong, Guangdong Guangxin Innovation Research Institute Co., Ltd. CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong cancelled the transaction announced on March 20, 2022 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong(XSSC:600866) added to S&P Global BMI Index CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong completed the acquisition of a 99.22% stake in Ningxia EPPEN Biotech Co.,ltd from a group of sellers. CI
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Star Lake Bioscience to Raise $208 Million for Biotech Firm Purchase MT
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Reports Earnings Results for the Half Year Ended June 30, 2022 CI
More news
1 day-6.88%
1 week-10.49%
Current month+26.68%
1 month+72.77%
3 months+77.04%
6 months+36.05%
Current year+53.86%
More quotes
1 week
6.93
Extreme 6.93
8.35
1 month
4.18
Extreme 4.18
8.78
Current year
3.35
Extreme 3.35
8.78
1 year
3.35
Extreme 3.35
8.78
3 years
3.35
Extreme 3.35
9.34
5 years
3.35
Extreme 3.35
9.34
10 years
2.89
Extreme 2.89
9.65
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 19-09-23
Director of Finance/CFO 49 21-10-14
Director/Board Member 51 23-09-12
Members of the board TitleAgeSince
Director/Board Member 55 13-09-17
Director/Board Member 56 11-01-31
Director of Finance/CFO 48 20-02-13
More insiders
Date Price Change Volume
24-05-17 7.17 -6.88% 232,353,000
24-05-16 7.7 +2.39% 240,105,100
24-05-15 7.52 -4.20% 248,526,700
24-05-14 7.85 -4.03% 278,949,100
24-05-13 8.18 +2.12% 290,691,200

End-of-day quote Shanghai S.E., May 16, 2024

More quotes
STAR LAKE BIOSCIENCE CO., INC. ZHAOQING GUANGDONG is a China-based company principally engaged in the bio-chemical and bio-fermentation business. The Company's principal products are biochemical drugs, feed additives and food additives, including nucleotide additives, amino acid feed additives, nucleoside and nucleotide bulk pharmaceutical chemicals (BPCs), as well as amino acid BPC and intermediates. The Company mainly sells its products in domestic and overseas markets.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.17 CNY
Average target price
7.92 CNY
Spread / Average Target
+10.46%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600866 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW